{
    "2019-01-30": [
        [
            {
                "time": "2019-01-25",
                "original_text": "Value Stocks to Buy for 2019 and Beyond",
                "features": {
                    "keywords": [
                        "value",
                        "stocks",
                        "buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-25",
                "original_text": "ABBV Stock Is Worth a Look at Multi-Year Lows",
                "features": {
                    "keywords": [
                        "ABBV",
                        "stock",
                        "multi-year lows"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-25",
                "original_text": "3 Big Pharmas Expecting a Softer 2019",
                "features": {
                    "keywords": [
                        "big pharmas",
                        "softer",
                        "2019"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-25",
                "original_text": "Genentech kills big drug study in early Alzheimer's patients",
                "features": {
                    "keywords": [
                        "Genentech",
                        "drug study",
                        "Alzheimer's"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-25",
                "original_text": "AbbVie Reports Improvement in Margins in Fiscal 2018",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "improvement",
                        "margins",
                        "fiscal 2018"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-25",
                "original_text": "A Look at AbbVieâ€™s Diversified Product Portfolio in Fiscal 2019",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "diversified",
                        "product portfolio",
                        "fiscal 2019"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-25",
                "original_text": "Jim Cramer Gives His Opinion On AbbVie, Idexx Labs And More",
                "features": {
                    "keywords": [
                        "Jim Cramer",
                        "opinion",
                        "AbbVie",
                        "Idexx Labs"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-25",
                "original_text": "Edited Transcript of ABBV earnings conference call or presentation 25-Jan-19 2:00pm GMT",
                "features": {
                    "keywords": [
                        "ABBV",
                        "earnings",
                        "conference call",
                        "presentation"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-25",
                "original_text": "AbbVie (ABBV) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "gains",
                        "market dips"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}